FLUI.ST

Fluicell AB (publ) [FLUI.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

FLUI.ST Stock Summary

Top 10 Correlated ETFs

FLUI.ST

Top 10 Correlated Stocks

FLUI.ST

In the News

FLUI.ST Financial details

Company Rating
-
Market Cap
38.59M
Income
-26.56M
Revenue
3.34M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
17
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-0.88
Forward P/E
-
PEG
0.34
P/S
6.19
P/B
2.65
P/C
-
P/FCF
-1.16
Quick Ratio
1.5
Current Ratio
2.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.24
EPS next Y
-
EPS next Q
-
EPS this Y
-25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.33%
Revenue last 5Y
6.05%
Revenue Q/Q
-20.68%
EPS Q/Q
32.88%
-
-
-
-
SMA20
-28.13%
SMA50
-25.26%
SMA100
-38.4%
Inst Own
-
Inst Trans
-
ROA
-184%
ROE
-158%
ROC
-3.02%
Gross Margin
67%
Oper. Margin
-565%
Profit Margin
-563%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.029255-0.951
52W High
-
52W Low
-
RSI
41.81
Rel Volume
-
Avg Volume
5.6M
Volume
890
Perf Week
4.81%
Perf Month
-36.62%
Perf Quarter
-51.45%
Perf Half Y
-49.48%
-
-
-
-
Beta
1.678
-
-
Volatility
0.27%, 2.45%
Prev Close
-0.33%
Price
12.2
Change
-3.48%

Something similar

Top by Market Cap
BRH.DE
ABEA.DE
AMZN
M&M.NS
NVDA
Top Correlated ETFs
LXUU.L
GLCB.L
VVSM.DE
XMLD.DE
RS2G.L
Top Correlated Stocks
0293.HK
2455.TW
1540.TW
3011.TW
ZINC.L
Similar Market Cap
WMC
IEIH
8431.HK
IINN
ENPIX

Company Profile

Healthcare Biotechnology
  • Volume Average 5.6M
  • Market Capitalization 38.59M
  • Employee 17
  • CEO Ms. Victoire Viannay
  • Headquarters Gothenburg,SE
  • IPO Date 2018-04-18
  • Website https://www.fluicell.com

Fluicell AB (publ) provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company offers BioPen PRIME and BioPen FLEX microfluidic systems for maintaining localized solution delivery in single-cell experiments, as well as enabling control of the chemical environment around single intact cells in tissue or cell cultures; and Dynaflow Resolve system, a secondary ion channel screening platform, which allows for recording of various ion channel current in patch-clamp recording configuration. The company was founded in 2012 and is based in Gothenburg, Sweden.